Transitional cell carcinoma (TCC) is the most common cancer of the urinary bladder and orginates from the normal stratified transitional epithelium, the urothelium. The natural history of TCC is unclear as it is currently not possible to distiguish the 3% subgroup of patients with superficial noninvasive papillary disease who will progress to muscleinvasive malignant disease from those patients in whom the diseas is less aggressive. It is thought that the homozygous loss of a tumour-suppressor gene may be the initiating factor in bladder cancer and interest has centred on chromosome 9, which shows a high rate of allelic loss that is both stage and grade independent (Cairns et al., 1993; Miyao et al., 1993; Ruppert et al., 1993; Stadler et al., 1994) . Deletion mapping studies of primary bladder tumours indicate the presence of two independent tumour-suppressor loci on chromosome 9, located proximally on 9p and 9q (Ruppert et al., 1993; Keen and Knowles, 1994) . In two independent studies, the 9p locus has been mapped to the 9p21-22 region (Caims et al., 1994a; Stadler et al., 1994) .
The 9p21-22 region is also implicated in tumour development of a wide spectrum of other human tumours, including familial and sporadic melanoma (Cannon-Albright et al., 1992; Fountain et al., 1992; Hussussian et al., 1994; Kamb et al., 1994a) . The location of the p16 cyclin-dependent kinase 4 vnibitor (Cdk41) gene at 9p21 has led to the hypothesis that inhibitors of GI/S cell cycle progression may show tumoursuppressor function and hence have oncogenic activity if homozygously lost through deletion and/or mutation (reviewed by Hartwell and Kastan, 1994; Marx, 1994a) . In addition to p16 (Serrano et al., 1993) , three other Cdk inhibitors have been identified: p15 (Hannon and Beach, 1994) , p21 (El-Diery et al., 1993; Harper et al., 1993; Xiong et al., 1993a) and p27 (Polyak et al., 1994a; Toyoshima and Hunter, 1994) and these too have the potential to act as tumour-suppressors or to confer growth advantage in vitro. Transcription of p21 is stimulated by p53 (El-Deiry et al., 1993) and by cell senescence (Noda et al., 1994) and expression of p21 protein is reduced in cells with null p53 (Xiong et al., 1993b) . The p15 and p27 inhibitors are each implicated in TGF-p-mediated GI phase arrest (Hannon and Beach, 1994; Polyak et al., 1994b lines were used: RT4, RT112, HT1376, HT1197, COL0232,  KK47, VM-CUB-1, VM-CUB-3, 253J, EJ, HU456, HU961T,  MGH-U2, T24, TCCSUP, HCV29 and SCaBER. These cell lines have been reviewed and referenced by Masters et al. (1986) . The cell lines were m tained in a 1:1 mixture of RPMI-1640 and Dulbecco's modified Eagle medium (DMEM) with 5% fetal bovine serum (FBS), as described previously (Trejdosiewicz et al., 1985 Figure 2 .
Detection of cyclin-ependent kinase inhibitor gene sequences These results are summarised in Table I and illustrated in Figure 3 . Using the specific pi6 primers, the expected 167 bpsized single product was amplified by PCR from human placental DNA (included as a positive control) and with DNA from ten of the 17 bladder cell lines. Using the same optimised PCR conditions, no product could be amplified from any of the remaining seven cell lines (RT4, RT112, VM-CUB-1, VM-CUB-3, COL0232, 253J and HCV29). The ten p16-positive cell lines included all five of the cell lines suspected of cross-contamination. When only independent cell lines were considered, 6/13 were positive for p16. The specific pi5 primers amplified the expected single 430 bp product from the control human placental DNA and from the same ten bladder cell lines which were positive for pi6 (above), including all five cell lines suspected of crosscontamination. All seven p16-negative cell lines failed to amplify any product with the p15-specific primers. Using the p27 primers. a single PCR product of 186 bp was amplified from control DNA and from all of the 13 independent bladder cell lines. The integrity of all the genomic DNA preparations was confirmed by successful amplification of a 682 bp product from the 5' flanking region of the human LD78a gene on chromosome 17q.
Discussio
Recent advances in understanding how regulation of the cell cycle is achieved through the coordinated activity of cycindependent kinases and checkpoint controls has revealed groups of genes with hitherto unforeseen oncogenic and tumour-suppressor potential (Hartwell and Kastan, 1994: Marx. 1994a (Cairns et al., 1994b; Spruck et al., 1994) has thrown the role of p16 as a major multiple tumoursuppressor gene into some dispute (Bonetta, 1994; Marx, 1994b : Wainwright. 1994 ). An alternative hypothesis is that loss of p16 confers a selective growth advantage during adaptation of tumour cells to culture and hence is important in the generation of bladder cancer cell lines (Cairns et al., 1994b; Spruck et al., 1994; Yeager et al., 1995 Junien and Henry, 1994) . Nevertheless, the seven p16-negative bladder cancer cell lines all contained at least one cytogenetically normal 9p21 region, demonstrating that loss of the pl6 gene was too small to be detected cytogenetically. This is consistent with the data of Nobori et al. (1994) (Bonetta, 1994; Spruck et al., 1994) .
The adaptation of tumours to growth in vitro places rigorous selection pressures on the individual tumour cells. Indeed, compared with normal bladder epithelium (Southgate et al., 1994) , the majority of primary bladder tumours do not readily adapt to in vitro growth (Niell and Soloway, 1983, and unpublished observations). Derangement (Sidransky et al., 1991) and, as yet, it is unknown whether loss of p16 or p21 function could offer differential survival benefits in vitro. Our studies suggest that the p27 gene is not commonly homozygously deleted in human bladder cancers. However, further studies will be needed to determine whether loss of p27 protein function is important either in bladder tumour progression and/or in the evolution of bladder tumour cell lines.
